The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BrUOG 324: Adjuvant nivolumab and low-dose ipilimumab for stage IIC, III, and resected stage IV melanoma: A phase II Brown University Oncology Research Group trial.
 
Maria Constantinou
No Relationships to Disclose
 
Michael P. Vezeridis
Honoraria - Castle Biosciences
Consulting or Advisory Role - Castle Biosciences
 
Martin A. Weinstock
No Relationships to Disclose
 
Joanna Walker
No Relationships to Disclose
 
Thomas J. Miner
No Relationships to Disclose
 
Peter Barth
No Relationships to Disclose
 
Kayla Rosati
No Relationships to Disclose
 
Kristen Mitchell
No Relationships to Disclose
 
Sopha Dionson
No Relationships to Disclose
 
Wendy Turchetti
No Relationships to Disclose
 
John Vatkevich
No Relationships to Disclose
 
William Matthew Rafelson
No Relationships to Disclose
 
Kalyan C. Mantripragada
No Relationships to Disclose
 
Howard Safran
No Relationships to Disclose